Pharma

Ajinomoto Bio-Pharma and Gene Tools partner on PMO therapy

Ajinomoto Bio-Pharma Services has partnered with Gene Tools, LLC. This partnership aims to increase access to phosphorodiamidate morpholino oligomers (PMOs). PMOs are unique oligonucleotide therapies. They can help treat genetic diseases like Duchenne muscular dystrophy (DMD). This partnership addresses a big problem in early-stage research. It allows for the production of purified PMOs in small amounts. Then, it connects smoothly to GLP and GMP manufacturing for clinical development. PMOs are special oligonucleotides. They need precise manufacturing skills. Gene Tools, a top name in small-scale PMO synthesis, will offer pre-purified PMOs to researchers around the globe. Aji Bio-Pharma will use its AJIPHASE® liquid-phase tech for purification and quality control. With deep experience in large-scale GLP and GMP production, they ensure top quality. The collaboration creates a clear path. The journey begins…